Skye Bioscience, INC. (SKYE) SEC Filings — 2025
9 SEC filings for Skye Bioscience, INC. (SKYE) in 2025.
Filings
- Skye Bioscience, INC. 8-K Filing — 8-K · Dec 23, 2025
- Skye Bioscience's Losses Mount Amid R&D Surge, Nimacimab Fails Phase 2a — 10-Q · Nov 10, 2025
- Skye Bioscience Files 8-K — 8-K · Oct 6, 2025
- Skye Bioscience Losses Widen Amid R&D Push — 10-Q · Aug 7, 2025
- Skye Bioscience Files 8-K: Accountant, Shareholder Votes, Exhibits — 8-K · Jun 11, 2025
- Skye Bioscience Q1 2025 10-Q Filed — 10-Q · May 8, 2025
- Skye Bioscience Files Definitive Proxy Statement — DEF 14A · Apr 25, 2025
- Skye Bioscience Files 2024 10-K — 10-K · Mar 20, 2025
- Skye Bioscience Files 8-K on Director/Officer Changes — 8-K · Feb 26, 2025